In individuals with T2D, monotherapy often fails to maintain adequate glucose control, leading to the recommendation of combination therapy in clinical practice [6]
And, as critics have pointed out over the years, by elevating just one, two, or at most, three researchers, the Nobels distort the history of science by personalizing discoveries that are truly made by groups of individuals. That reality hangs heavy especially over a decision about GLP-1 and other gut-hormone based drugs, given how much additional science had to be done to convert the hormones to effective, and then even more effective, drugs
Retatrutide dosing comes from the Phase 3 TRIUMPH program titration
Science Translational Medicine
Its the same reason somebody doesnt tell you when they had a facelift or had any other work done
doi: 10.3389/fpls.2016.01166 49 PoustkaF.IraniN